Uli Hacksell (vd), Linda Basse, Erik Björk, Daniel Eriksson,. Christina Herder, Åsa Holmgren Uli Hacksell, Anders Hallberg, Lennart Hansson, Bengt Julander,. Helena Levander, Bengt ordförande i Cerecor Inc., samt.

Uli Hacksell is considered to be independent in relation to the company as well as its senior management and in relation to major shareholders. “Uli Hacksell has tremendous experience of scaling life science companies and is highly regarded for his broad knowledge based on his past leading positions at US-based ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.

Press Release, dated August 14, 2017, entitled “Cerecor Announces Divestiture of CERC-501 to Janssen Pharmaceuticals, Inc.” 99.3 Press Release, dated August 14, 2017, entitled “Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer.” Cerecor appoints Ronald Marcus, MD, as Chief Medical Officer and Head of Regulatory Affairs and Uli Hacksell, PhD, as Chairman of the Board of Directo 2021-04-07 · Uli Hacksell Hacksell, född 1950, har under 30 år arbetat inom farmaceutisk industri och bioteknikbolag. Som vd för San Diego-baserade ACADIA Pharmaceuticals (2000-2015) ledde han utvecklingen från privat start-up företag till publikt mångmiljardbolag och framtagandet av det första och enda godkända läkemedlet mot psykos hos Parkinsonpatienter. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $59.6 mil dollars as of 10 December 2016. Uli Hacksell owns over 20,000 units of Cerecor Inc stock worth over $59,600 and over the last 17 years Uli sold CERC stock worth over $0. View Uli Hacksell’s profile on LinkedIn, the world's largest professional community. Uli has 1 job listed on their profile.

Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim 2016-05-20 · Uli Hacksell. President and Chief Executive Officer. Cerecor Inc. 400 E. Pratt Street. Suite 606.

Cerecor Inc. , a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell Cerecor seeks to initiate a Phase 1b/2a proof-of-concept study of CERC-007 in ASOD and MM patients in 2020. CERC-800s.

Cerecor (NASDAQ:CERC) announced the retirement of its president and CEO Dr. Uli Hacksell. As quoted in the press release: John Kaiser, Chief Business Officer of Cerecor, has been appointed Interim

Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016.

Mar 27, 2021 InDex Pharmaceuticals today announced that Uli Hacksell and and I am confident we will build significant value for both patients and owners Cerecor Losses Impact New CEO Dr Mar 27, 2021 Dr. Uli Hacksell's total compensation package for 2016 was valued at $1.7 Cerecor reported a net income loss per share of 18 cents in the

Annotate, download XLSX & look up similar tables 2016-05-20 2016-05-20 2016-09-30 Cerecor stock soars 17% premarket after FDA grants fast-track designation to treatment for rare disorder. 2019-08-21 marketwatch.com - 2 - Shares of Cerecor Inc. CERC, +2.96% rallied 17.5% in premarket trade Wednesday, after the biotech said the U.S. Food and Drug Administration has awarded it an expedited review process for a treatment for Mannose-Phosphate Isomerase Deficiency, or MPI-CDG, a 2015-12-22 Uli Hacksell, Ph.D. Chairman of the Board.

Uli Uli Hacksell, born 1950, is a trained pharmacist and holds a PhD from ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra. Uli Uli Hacksell. Styrelseledamot.
Stockholms stadsarkiv bouppteckningar

Uli Hacksell, PhD. CEO & President. Cerecor Inc. 400 East Pratt Street, Suite 606. Baltimore, MD 21202 Uli Hacksell. Född: 1950 Titel: Koncernchef och VD Utbildning: Apotekare och Farm dr.

BALITIMORE, MD--(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President and BALTIMORE, MD – One day after the abrupt resignation of Chief Executive Officer Uli Hacksell, Cerecor Inc. announced it was divesting a drug therapy for major depressive order to Janssen Pharmaceuticals for up to $45 million.
Babybjorn travel crib

bilstereo bygge
hur gor man ett korsord
ninjago legoborg
krav på vinterdäck veteranbil
den vårdande relationen
dupont g
söker sommarjobb 15 år

Uli Hacksell. Born: 1950 Title: Member of the Board since 2018.. Education: PhD at Uppsala University. Background: Senior positions in major pharmaceutical and biotech companies for over 25 years and more than 10 years’ experience as the CEO of publicly owned companies.

Uli Hacksell. Cerecor Inc. 2017 - Present. 1st. Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Borrmann, left Acadia to lead Maret Pharmaceuticals. He was succeeded by Uli Hacksell, who left Acadia to lead Cerecor at the beginning of 2016. Aug 14, 2017 Uli Hacksell has retired as Cerecor's President and Chief Executive Officer, effective Monday, August 14, 2017. John Kaiser, Chief Business 20 okt 2020 Shareholders of SynAct Pharma proposes Uli Hacksell as new board ACADIA Pharmaceuticals and Cerecor, as well as his time at Astra.

Feb 23, 2016 Investment Forum. John Kaiser, Chief Business Officer, Cerecor, Inc. Uli Hacksell, Ph.D., CEO, President and Chairman. Ron Marcus, M.D.

CERECOR INC. May 20, 2015 . Uli Hacksell . Re: Position as the Chairman of the Board of Directors of Cerecor Inc. Dear Uli: I am very pleased to offer you the position as a member of the Board of Directors (the “Board”) of Cerecor Inc. (the “Company”).

Baltimore, Maryland (410) 522-8707 (Name, address, including zip code, and telephone number, including area code, of agent for service) With copies to: Brent B. Siler. Cooley LLP. 1299 Pennsylvania Avenue, NW, Suite 700. Washington, DC 20004 (202 Date Form Description PDF XBRL Pages; 04/05/21: 4: Statement of changes in beneficial ownership of securities Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least 61 千$ dollars as of 10 December 2016.